Microarray profiling analysis identifies the mechanism of miR‐200b‐3p/mRNA‐CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor‐γ signaling pathway
Authors:
- 2 December 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (4) , 5193-5206
Abstract
Objective: Current study focused on the influence of miR‐200b‐3p on cardiocyte apoptosis of diabetic cardiomyopathy (DCM) by regulating CD36 and peroxisome proliferator‐activated receptor γ (PPAR‐γ) signaling pathway.Methods: Bioinformatic analysis was used to analyze differentially expressed microRNA (miRNAs), messenger RNAs (mRNAs) and activated pathways in DCM. And then quantitative real‐time polymerase chain reaction (qRT‐PCR) was conducted to verify expression of miR‐200b‐3p and CD36 in DCM model rats and glucose treated H9c2 cell line. Luciferase reporter assay was used to verify the transcriptional regulation of agomiR‐200b‐3p and investigate the relationship between miR‐200b‐3p and CD36. Flow cytometry was performed to assess cardiocyte apoptosis in different interference conditions. Echocardiography was used to illustrate the ejection fraction rate and fraction shortening rate of DCM model rats. Next, hematoxylin‐eosin (H&E) staining assay was carried out to reveal structures of cardiocyte tissues with transfection in different conditions. Masson trichrome staining was used to evaluate myocardial fibrosis. Western blot analysis was used to detect the expression levels of PPAR‐γ signaling‐related protein PPAR‐γ and Bcl‐2.Results: miR‐200b‐3p was low‐expressed while CD36 was overexpressed in DCM. AgomiR‐200b‐3p could inhibit the expression of CD36 to regulate cardiocyte apoptosis in DCM. CD36 activated PPAR‐γ signaling pathway in DCM. Silencing CD36 or GW9662 treatment protect rat against DCM.Conclusion: miR‐200b‐3p targeted CD36 to regulate cardiocyte apoptosis of DCM by activating PPAR‐γ signaling pathway.Keywords
Funding Information
- Applied and fundamental study of Sichuan Province (2017JY0026)
This publication has 20 references indexed in Scilit:
- MicroRNAs in diabetic cardiomyopathy and clinical perspectivesFrontiers in Genetics, 2014
- Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathwaysPharmacology & Therapeutics, 2014
- Expression Profiling of PPARγ-Regulated MicroRNAs in Human Subcutaneous and Visceral Adipogenesis in both GendersEndocrinology, 2014
- FOG2 Protein Down-regulation by Transforming Growth Factor-β1-induced MicroRNA-200b/c Leads to Akt Kinase Activation and Glomerular Mesangial Hypertrophy Related to Diabetic NephropathyJournal of Biological Chemistry, 2013
- CD36 as a target to prevent cardiac lipotoxicity and insulin resistanceProstaglandins, Leukotrienes and Essential Fatty Acids, 2013
- CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytesBiochemical Journal, 2012
- Ginsenoside-Rb1 Promotes Adipogenesis Through Regulation of PPARγ and MicroRNA-27bHormone and Metabolic Research, 2012
- MicroRNAs in diabetes and diabetes-associated complicationsRNA Biology, 2012
- Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic DiseasePhysiological Reviews, 2010
- Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator–Activated Receptor γ in Cardiac FibrosisDiabetes, 2008